145 related articles for article (PubMed ID: 35147070)
1. The combination of MnO
Zhang J; Xu L; Hu H; Chen E
Drug Deliv; 2022 Dec; 29(1):466-477. PubMed ID: 35147070
[TBL] [Abstract][Full Text] [Related]
2. Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer.
Hu Y; Zhang J; Hu H; Xu S; Xu L; Chen E
Cell Cycle; 2020 Dec; 19(24):3581-3594. PubMed ID: 33300430
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-mediated MSNs@Ag@Geb multifunctional nanocomposite heterogeneous platform for combined therapy of non-small cell lung cancer.
Lin J; Zheng R; Huang L; Tu Y; Li X; Chen J
Colloids Surf B Biointerfaces; 2022 Sep; 217():112639. PubMed ID: 35759894
[TBL] [Abstract][Full Text] [Related]
4. pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer.
Zhu R; Wang Q; Zhu Y; Wang Z; Zhang H; Wu B; Wu X; Wang S
Acta Biomater; 2016 Jan; 29():320-332. PubMed ID: 26485164
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab.
Pang J; Xing H; Sun Y; Feng S; Wang S
Biomed Pharmacother; 2020 May; 125():109861. PubMed ID: 32070872
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO
Lin LS; Song J; Song L; Ke K; Liu Y; Zhou Z; Shen Z; Li J; Yang Z; Tang W; Niu G; Yang HH; Chen X
Angew Chem Int Ed Engl; 2018 Apr; 57(18):4902-4906. PubMed ID: 29488312
[TBL] [Abstract][Full Text] [Related]
7. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
Sun C; Gao W; Liu J; Cheng H; Hao J
Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
[TBL] [Abstract][Full Text] [Related]
8. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
9. CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo.
Zhang K; Wang L; Wei A; Jia X; Liu X
Thorac Cancer; 2020 Jun; 11(6):1566-1577. PubMed ID: 32368855
[TBL] [Abstract][Full Text] [Related]
10. A Core-Shell Nanoplatform for Synergistic Enhanced Sonodynamic Therapy of Hypoxic Tumor via Cascaded Strategy.
Wang L; Niu M; Zheng C; Zhao H; Niu X; Li L; Hu Y; Zhang Y; Shi J; Zhang Z
Adv Healthc Mater; 2018 Nov; 7(22):e1800819. PubMed ID: 30303621
[TBL] [Abstract][Full Text] [Related]
11. Engineering EHD1-Targeted Natural Borneol Nanoemulsion Potentiates Therapeutic Efficacy of Gefitinib against Nonsmall Lung Cancer.
Yuan R; Huang Y; Chan L; He D; Chen T
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45714-45727. PubMed ID: 32927941
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-loaded mesoporous polydopamine nanoparticles capped with MnO
Zhang Y; Williams GR; Wang T; Zheng Y; Xu J; Nguyen VC; Yao L; Wang H; Zhu LM
Int J Pharm; 2024 May; 656():124093. PubMed ID: 38583822
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells.
Li A; Cao W; Liu X; Zhang Y; Ma Y; Xu R; Zhang R; Liu X; Zhou S; Wang R; Liu J; Tang X
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1737-1749. PubMed ID: 32342201
[TBL] [Abstract][Full Text] [Related]
14. Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1.
Zhang Q; Chen M; Cao L; Ren Y; Guo X; Wu X; Xu K
Mol Carcinog; 2020 Jun; 59(6):590-603. PubMed ID: 32189414
[TBL] [Abstract][Full Text] [Related]
15. Investigation of PPIX-Lipo-MnO
Chudal L; Pandey NK; Phan J; Johnson O; Li X; Chen W
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109979. PubMed ID: 31500001
[TBL] [Abstract][Full Text] [Related]
16. Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer.
Yang Q; Chen W; Xu Y; Lv X; Zhang M; Jiang H
Toxicol Appl Pharmacol; 2018 Oct; 356():1-7. PubMed ID: 30076870
[TBL] [Abstract][Full Text] [Related]
17. Preparation of responsive "dual-lock" nanoparticles and their application in collaborative therapy based on CuS coordination.
Jia C; Zhang M; He XW; Li WY; Zhang YK
J Mater Chem B; 2021 Jan; 9(4):1049-1058. PubMed ID: 33399610
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application.
Hao Y; Wang L; Zhang B; Zhao H; Niu M; Hu Y; Zheng C; Zhang H; Chang J; Zhang Z; Zhang Y
Nanotechnology; 2016 Jan; 27(2):025101. PubMed ID: 26629735
[TBL] [Abstract][Full Text] [Related]
19. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
[TBL] [Abstract][Full Text] [Related]
20. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
